Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05436145 · ClinicalTrials.gov registry record · NA

Intern Health Study 2022 and 2023

A NA study of Depression and Sleep, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
2,562
Enrollment target
1
Study location

NCT05436145: Completed NA study of Depression and Sleep, sponsored by University of Michigan.

NCT05436145 is a NA study of Depression and Sleep that has completed, run by University of Michigan. The registered enrollment target is 2,562 participants, above the 782-participant average among 679 other Depression trials with a reported enrollment target (228% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05436145, a NA study of Depression and Sleep, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
2,562 participants
Enrollment target
1
Study location

Study Summary

The aim of this trial is to evaluate the efficacy of an intervention (delivered through a smartphone) for improving the mood, physical activity, and sleep of medical interns.

Primary Outcome

Through the mobile app, participants enter a mood score (scale 1 - 10) every day of the study. 1 corresponds to lowest mood and 10 corresponds to highest mood.

Interventions

  • BEHAVIORAL Intern Health Study behavioral change mobile notification

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 2,562 participants
Start Date 2022-07-01
Est. Completion 2024-06-30
Phase NA
University of Michigan

1,327 total trials

What the finished NCT05436145 record still lists

NCT05436145 is an interventional study that assigns participants to a tested intervention. Its 2,562 participants enrollment target places it among the larger protocols in the corpus, above the 782-participant average among 679 other Depression trials with a reported enrollment target (228% higher).

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Intern Health Study behavioral change mobile notification is the first listed.

NCT05436145 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT05436145 about?

NCT05436145 is a clinical study titled "Intern Health Study 2022 and 2023". The aim of this trial is to evaluate the efficacy of an intervention (delivered through a smartphone) for improving the mood, physical activity, and sleep of medical interns.

What is the current status of trial NCT05436145?

This trial is currently completed. It is a NA study. The enrollment target is 2,562 participants. The study started on 2022-07-01. Estimated completion is 2024-06-30.

What conditions does trial NCT05436145 study?

This clinical trial studies the following conditions: Depression, Sleep, Physical Activity, Mood.

What interventions are being tested in trial NCT05436145?

The interventions under investigation include: Intern Health Study behavioral change mobile notification (BEHAVIORAL).

Who is sponsoring clinical trial NCT05436145?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05436145 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05436145's enrollment target sits among peer trials

2,562 21st of 679 higher than 659 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06018285 · 2,572 participants · NA

    Stepped Approach to Reducing Risk of Suicide in Primary Care

  • NCT05931276 · 2,540 participants · Phase 3

    CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

  • NCT06370520 · 2,592 participants

    Screening Emotions in Adolescents at the Hospital for mTBI

  • NCT00018057 · 2,530 participants · Phase 2

    Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT05436145, the US trial registry maintained by the National Library of Medicine. NCT05436145 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.